Search

Author/Creator Heinrich, Michael C.

1. Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial. (March 2021)

Authors:
Jones, Robin L.; Serrano, César; von Mehren, Margaret; George, Suzanne; Heinrich, Michael C.; Kang, Yoon-Koo; Schöffski, Patrick; Cassier, Philippe A.; Mir, Olivier; Chawla, Sant P.; Eskens, Ferry A.L.M.; Rutkowski, Piotr; Tap, William D.; Zhou, Teresa; Roche, Maria; Bauer, Sebastian
Journal:
European journal of cancer
Issue:
Volume 145(2021)
Page Start:
132
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study. Issue 28 (1st October 2021)

Authors:
Kang, Yoon-Koo; George, Suzanne; Jones, Robin L.; Rutkowski, Piotr; Shen, Lin; Mir, Olivier; Patel, Shreyaskumar; Zhou, Yongjian; von Mehren, Margaret; Hohenberger, Peter; Villalobos, Victor; Brahmi, Mehdi; Tap, William D.; Trent, Jonathan; Pantaleo, Maria A.; Schöffski, Patrick; He, Kevin; Hew, ...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 28(2021)
Page Start:
3128
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Case series of chronic myeloid leukemia patients who maintained deep molecular response (DMR) with very low-dose ponatinib: experience in discontinuing low-dose ponatinib and treatment-free remission (TFR) outcomes. Issue 10 (23rd August 2020)

Authors:
Cohen, Jonathan; Palumbo, Alison; Wing, Jason; Heinrich, Michael C.
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 10(2020)
Page Start:
2511
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study. (16th August 2021)

Authors:
Zalcberg, John R.; Heinrich, Michael C.; George, Suzanne; Bauer, Sebastian; Schöffski, Patrick; Serrano, César; Gelderblom, Hans; Jones, Robin L.; Attia, Steven; D'Amato, Gina; Chi, Ping; Reichardt, Peter; Somaiah, Neeta; Meade, Julie; Reichert, Vienna; Shi, Kelvin; Sherman, Matthew L.; Ruiz-Soto...
Journal:
Oncologist
Issue:
Volume 26:Number 11(2021)
Page Start:
e2053
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Clinical Benefit of Ripretinib Dose Escalation After Disease Progression in Advanced Gastrointestinal Stromal Tumor: An Analysis of the INVICTUS Study. (16th August 2021)

Authors:
Zalcberg, John R.; Heinrich, Michael C.; George, Suzanne; Bauer, Sebastian; Schöffski, Patrick; Serrano, César; Gelderblom, Hans; Jones, Robin L.; Attia, Steven; D'Amato, Gina; Chi, Ping; Reichardt, Peter; Somaiah, Neeta; Meade, Julie; Reichert, Vienna; Shi, Kelvin; Sherman, Matthew L.; Ruiz‐Soto...
Journal:
Oncologist
Issue:
Volume 26:Number 11(2021)
Page Start:
e2053
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumour. (July 2016)

Authors:
Wagner, Andrew J.; Agulnik, Mark; Heinrich, Michael C.; Mahadevan, Daruka; Riedel, Richard F.; von Mehren, Margaret; Trent, Jonathan; Demetri, George D.; Corless, Christopher L.; Yule, Murray; Lyons, John F.; Oganesian, Aram; Keer, Harold
Journal:
European journal of cancer
Issue:
Volume 61(2016)
Page Start:
94
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumour. (July 2016)

Authors:
Wagner, Andrew J.; Agulnik, Mark; Heinrich, Michael C.; Mahadevan, Daruka; Riedel, Richard F.; von Mehren, Margaret; Trent, Jonathan; Demetri, George D.; Corless, Christopher L.; Yule, Murray; Lyons, John F.; Oganesian, Aram; Keer, Harold
Journal:
European journal of cancer
Issue:
Volume 61(2016)
Page Start:
94
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Gene expression of the IGF pathway family distinguishes subsets of gastrointestinal stromal tumors wild type for KIT and PDGFRA. (18th January 2013)

Authors:
Beadling, Carol; Patterson, Janice; Justusson, Emily; Nelson, Dylan; Pantaleo, Maria A.; Hornick, Jason L.; Chacón, Matias; Corless, Christopher L.; Heinrich, Michael C.
Journal:
Cancer medicine
Issue:
Volume 2:Number 1(2013:Feb.)
Page Start:
21
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Hepatic metastases in gastrointestinal stromal tumors: oncologic outcomes with curative-intent hepatectomy, resection of treatment-resistant disease, and tyrosine kinase inhibitor therapy alone. Issue 6 (June 2022)

Authors:
Sutton, Thomas L.; Walker, Brett S.; Billingsley, Kevin G.; Sheppard, Brett C.; Corless, Christopher L.; Heinrich, Michael C.; Mayo, Skye C.
Journal:
HPB
Issue:
Volume 24:Issue 6(2022)
Page Start:
986
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗